PBAC Public Summary Documents – December 2020

Page last updated: 23 April 2021

Public Summary Documents relating to the December 2020 PBAC meeting:

• Etanercept: Injection 50 mg in 1 mL single use auto-injector, 4; Injections 50 mg in 1 mL single use pre-filled syringes, 4; Brenzys®
• Nurse Practitioners as secondary reviewers for ongoing treatment with opioid medications

The following Public Summary Documents have been updated:

November 2020 PBAC meeting

• Sapropterin: Powder for oral solution 500 mg, Tablet (soluble) 100 mg; Kuvan®
• Glecaprevir and pibrentasvir: Tablet containing 100 mg glecaprevir with 40 mg pibrentasvir; Maviret®